Cigna Group (CI) Stock Price, News & Analysis

Company Overview

Cigna Group (NYSE: CI) is a global health services company dedicated to improving the health, well-being and peace of mind of the people it serves. The company operates through multiple segments to offer a broad range of employee benefits and health plans, including medical, dental, behavioral health, pharmacy and vision coverage. In addition to traditional insurance, Cigna provides health and wellness programs, care management services and digital health tools designed to help individuals and families access quality care and manage chronic conditions.

The company’s core businesses include Global Health Care, which delivers employer-sponsored medical and specialty benefits; Global Supplemental Benefits, offering accident, critical illness, hospital indemnity, life and disability coverage; and Group Disability and Life, providing income protection solutions for employees. Cigna also administers Medicare and Medicaid plans in the U.S., serving seniors and low-income populations through a range of government-sponsored programs. The company’s integrated pharmacy services combine mail-order, specialty pharmacy and retail networks to optimize medication management and cost efficiency.

Founded in 1792 as the Insurance Company of North America and later merging with Connecticut General Corporation in 1982 to form Cigna, the company has grown through both organic expansion and strategic acquisitions. Cigna’s international presence spans more than 30 countries, including operations in Asia, Europe, the Middle East and Latin America. Its global network of healthcare providers and partners supports individuals traveling or working abroad, as well as multinational corporations seeking consistent benefits across borders.

Headquartered in Bloomfield, Connecticut, Cigna is led by Chief Executive Officer David M. Cordani, who has overseen the company’s transformation into a diversified health services organization. Under his leadership, Cigna has emphasized consumer-centric solutions, digital innovation and value-based care models. The company’s strategic priorities focus on expanding access to affordable care, enhancing customer experience through technology and forging partnerships that address the evolving needs of patients, employers and communities worldwide.

Key Stats

• Today's Range: $306.34 to $311.82
• 50-Day Range: $301.90 to $335.21
• 52-Week Range: $262.03 to $370.83
• Volume: 989,330 shs
• Average Volume: 1.74 million shs
• Market Capitalization: $82.41 billion
• P/E Ratio: 17.08
• Dividend Yield: 1.96%
• Price Target: $380.39
• Consensus Rating: Buy

Cigna Group Stock Analysis - MarketRank™

Cigna Group scored higher than 100% of companies evaluated by MarketBeat, and ranked 8th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Cigna Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 16 buy ratings, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Cigna Group has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 3.8 / 5
• Proj. Earnings Growth: 10.95%

Earnings Growth

Earnings for Cigna Group are expected to grow by 10.95% in the coming year, from $29.77 to $33.03 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Cigna Group is 17.08, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.67.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cigna Group is 17.08, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.18.

Price to Earnings Growth Ratio

Cigna Group has a PEG Ratio of 0.93. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

Cigna Group has a P/B Ratio of 2.08. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.12% of the float of Cigna Group has been sold short.

Short Interest Ratio / Days to Cover

Cigna Group has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cigna Group has recently increased by 8.06%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Yield

Cigna Group pays a meaningful dividend of 1.94%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Cigna Group has been increasing its dividend for 5 years.

Dividend Coverage

The dividend payout ratio of Cigna Group is 33.44%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Cigna Group will have a dividend payout ratio of 18.29% next year. This indicates that Cigna Group will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 4.2 / 5
• Environmental Score: -0.19

Percentage of Shares Shorted

1.12% of the float of Cigna Group has been sold short.

Short Interest Ratio / Days to Cover

Cigna Group has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cigna Group has recently increased by 8.06%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 1.24

News Sentiment

Cigna Group has a news sentiment score of 1.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 25 news articles for Cigna Group this week, compared to 24 articles on an average week.

Search Interest

Only 16 people have searched for CI on MarketBeat in the last 30 days. This is a decrease of -27% compared to the previous 30 days.

MarketBeat Follows

Only 8 people have added Cigna Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -11% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Cigna Group insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.70% of the stock of Cigna Group is held by insiders.

Percentage Held by Institutions

86.99% of the stock of Cigna Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

CI Stock Analysis - Frequently Asked Questions

How have CI shares performed this year?

Cigna Group's stock was trading at $276.14 on January 1st, 2025. Since then, CI stock has increased by 11.7% and is now trading at $308.4750.

How were Cigna Group's earnings last quarter?

Cigna Group (NYSE:CI) posted its earnings results on Friday, May, 2nd. The health services provider reported $6.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.35 by $0.39. The business's quarterly revenue was up 14.4% on a year-over-year basis.
Read the conference call transcript.

Does Cigna Group have any subsidiaries?

Cigna Group subsidiaries include Express Scripts Holding Company, Brighter, Zurich Insurance Middle East, Alegis Care, Firstassist Insurance Services Ltd, Cigna HealthSpring, Choicelinx, and others.

Who are Cigna Group's major shareholders?

Top institutional shareholders of Cigna Group include Swedbank AB (0.19%), Wealth Enhancement Advisory Services LLC (0.04%), Livforsakringsbolaget Skandia Omsesidigt (0.04%) and Mn Services Vermogensbeheer B.V. (0.04%). Insiders that own company stock include David Cordani, Eric P Palmer, Brian C Evanko, Jason D Sadler, Michael W Triplett, Nicole S Jones, Donna F Zarcone, William J Delaney III, Noelle K Eder, Paul A Sanford, Cynthia Ryan, Elder Granger, Everett Neville and Hoeltzel Mary T Agoglia.
View institutional ownership trends.

How do I buy shares of Cigna Group?

Shares of CI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Cigna Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cigna Group investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Chevron (CVX), Advanced Micro Devices (AMD), Bristol Myers Squibb (BMY) and Adobe (ADBE).

Company Calendar

• Last Earnings: 5/02/2025
• Record date for 6/18 Dividend: 6/03/2025
• Ex-Dividend for 6/18 Dividend: 6/03/2025
• Dividend Payable: 6/18/2025
• Today: 7/10/2025
• Next Earnings (Estimated): 7/31/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED - HMO
• Sub-Industry: Managed Health Care
• Current Symbol: NYSE:CI
• CIK: 1739940
• Web: www.cigna.com
• Phone: (860) 226-6000
• Fax: 860-226-6741
• Employees: 73,500
• Year Founded: 1981

Price Target and Rating

• Average Price Target for Cigna Group: $380.39
• High Price Target: $438.00
• Low Price Target: $323.00
• Potential Upside/Downside: +22.3%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 20 Analysts

Profitability

• EPS (Trailing Twelve Months): $18.06
• Trailing P/E Ratio: 17.21
• Forward P/E Ratio: 10.45
• P/E Growth: 0.93
• Net Income: $3.43 billion
• Net Margins: 1.97%
• Pretax Margin: 2.68%
• Return on Equity: 18.63%
• Return on Assets: 4.97%

Debt

• Debt-to-Equity Ratio: 0.65
• Current Ratio: 0.72
• Quick Ratio: 0.72

Sales & Book Value

• Annual Sales: $247.12 billion
• Price / Sales: 0.34
• Cash Flow: $37.70 per share
• Price / Cash Flow: 8.25
• Book Value: $148.27 per share
• Price / Book: 2.10

Miscellaneous

• Outstanding Shares: 267,140,000
• Free Float: 265,273,000
• Market Cap: $83.09 billion
• Optionable: Optionable
• Beta: 0.44